Clinical indication

Dental implants without a bone graft. Rome, Italy

Have you been told you have too little bone for implants? In most cases that is not a closed door. The MTM approach makes it possible to place implants in narrow or deficient ridges without bone grafts, without barrier membranes and without synthetic materials, in a single surgical session.

Why the bone deficit forms

When a tooth is lost, or when it never developed, the alveolar bone that supported it loses its functional stimulus and resorbs. The bony ridge becomes narrower and lower, and the overlying gingival tissues shrink with it. This is the condition many studies describe as "insufficient bone": not the total absence of bone, but a residual volume inadequate for traditional implant protocols.

Often, after a three-dimensional radiographic examination (CBCT) and a careful clinical assessment, a case judged untreatable with other approaches is in fact among the elective indications for MTM.

How MTM solves the problem without adding bone

The conventional approach reasons by subtraction and addition: where bone is missing, it is added with grafts (autologous, xenogeneic or synthetic) protected by barrier membranes. Morphogenic Tissue Management reasons differently, in a biomimetic way: instead of "importing material", it creates the conditions for the body itself to regenerate its own bone and the overlying gingiva.

Through a controlled mechanical expansion of the ridge (Morphogenic Bone Splitting), the implant is placed and at the same time a space is created in which the periosteum and endosteum, the natural reserves of osteogenic cells, rebuild the osteo-muco-periosteal complex. No exogenous material, no membrane, no donor site to harvest from.

The three principles

  • One biology: we work with the patient's tissues, not against them. The risk of rejection, membrane exposure or post-operative complications is eliminated at the root.
  • One session: expansion, implant and tissue management take place in the same procedure in more than 90% of cases.
  • Short timelines: the entire treatment pathway is completed in 3-4 months, against the 12-18 months of traditional regenerative protocols.

MTM compared with traditional approaches

Bone graft + membrane (GBR)MTM approach
Materials addedHarvested or synthetic bone, barrier membranesNone: regeneration of the patient's own tissues
Surgical sessionsGenerally 3 or more (barring complications)One in 90% of cases
Overall duration12-18 months3-4 months
Risk of rejection / membrane exposurePresentAbsent
Donor sitePossible (harvesting)Not required

The comparison is not only about comfort. Fewer surgical phases and shorter operating times mean lower economic and biological costs, a faster recovery of function and esthetics, and a drastic reduction in post-operative complications.

A second opinion before accepting a graft

If you have been offered a large bone graft, or told that implants are not possible, it is worth requesting an assessment with the MTM approach. In many cases there is a shorter, less invasive path.

Frequently asked questions

Yes. The MTM approach was developed precisely for narrow ridges or ridges with a volume deficit. In most cases it allows the ridge to be expanded and the implant placed in the same session, without bone grafts or barrier membranes.

A diagnosis of insufficient bone usually refers to a ridge that is too thin for conventional protocols, not to an absolute contraindication. With MTM many of these cases are treatable without preliminary bone reconstruction. A second clinical opinion supported by a careful CBCT assessment is worthwhile.

Treatment is completed in 3-4 months, with a single surgical session in more than 90% of cases. Protocols with grafts and membranes generally require 12-18 months and 3 or more sessions (barring complications).

Because it creates the conditions for the periosteum and endosteum, the natural sources of osteogenic stem cells, to regenerate the bone in the space produced by ridge expansion. No exogenous material is introduced: the risk of rejection is nil and the biology of the site is respected.